Related references
Note: Only part of the references are listed.Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan: The SAMURAI-NVAF Study
Kazunori Toyoda et al.
INTERNATIONAL JOURNAL OF STROKE (2015)
Cardioembolic Stroke Is the Most Serious Problem in the Aging Society: Japan Standard Stroke Registry Study
Yuji Kato et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2015)
Acute Reperfusion Therapy and Stroke Care in Asia After Successful Endovascular Trials
Kazunori Toyoda et al.
STROKE (2015)
Early Recurrence and Cerebral Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation Effect of Anticoagulation and Its Timing: The RAF Study
Maurizio Paciaroni et al.
STROKE (2015)
Cardioembolic Stroke Is the Most Serious Problem in the Aging Society: Japan Standard Stroke Registry Study
Yuji Kato et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2015)
Association of improved outcome in acute ischaemic stroke patients with atrial fibrillation who receive early antithrombotic therapy: analysis from VISTA
A. H. Abdul-Rahim et al.
EUROPEAN JOURNAL OF NEUROLOGY (2015)
Meta-Analysis of Gender Differences in Residual Stroke Risk and Major Bleeding in Patients With Nonvalvular Atrial Fibrillation Treated With Oral Anticoagulants
Samir B. Pancholy et al.
AMERICAN JOURNAL OF CARDIOLOGY (2014)
Guidelines for Pharmacotherapy of Atrial Fibrillation (JCS 2013) - Digest Version
Hiroshi Inoue et al.
CIRCULATION JOURNAL (2014)
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
Christian T. Ruff et al.
LANCET (2014)
Global Sodium Consumption and Death from Cardiovascular Causes
Dariush Mozaffarian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Anticoagulation Intensity of Rivaroxaban for Stroke Patients at a Special Low Dosage in Japan
Takuya Okata et al.
PLOS ONE (2014)
Secular Trends in Ischemic Stroke Subtypes and Stroke Risk Factors
Chrysi Bogiatzi et al.
STROKE (2014)
Stroke prevention in atrial fibrillation: An Asian perspective
Chern-En Chiang et al.
THROMBOSIS AND HAEMOSTASIS (2014)
Confirmation of Model-based Dose Selection for a Japanese Phase III Study of Rivaroxaban in Non-valvular Atrial Fibrillation Patients
Masato Kaneko et al.
DRUG METABOLISM AND PHARMACOKINETICS (2013)
Edoxaban versus Warfarin in Patients with Atrial Fibrillation
Robert P. Giugliano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Relation of Gender-Specific Risk of Ischemic Stroke in Patients With Atrial Fibrillation to Differences in Warfarin Anticoagulation Control (from AFFIRM)
Renee M. Sullivan et al.
AMERICAN JOURNAL OF CARDIOLOGY (2012)
Rivaroxaban vs. Warfarin in Japanese Patients With Atrial Fibrillation - The J-ROCKET AF Study
Masatsugu Hori et al.
CIRCULATION JOURNAL (2012)
Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF
Graeme J. Hankey et al.
LANCET NEUROLOGY (2012)
Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial
J. Donald Easton et al.
LANCET NEUROLOGY (2012)
Nonvitamin-K-Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack A Systematic Review and Meta-Analysis of Randomized Controlled Trials
George Ntaios et al.
STROKE (2012)
Risks for Stroke, Bleeding, and Death in Patients With Atrial Fibrillation Receiving Dabigatran or Warfarin in Relation to the CHADS2 Score: A Subgroup Analysis of the RE-LY Trial
Jonas Oldgren et al.
ANNALS OF INTERNAL MEDICINE (2011)
Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial (vol 9, pg 1157, 2010)
H. C. Diener et al.
LANCET NEUROLOGY (2011)
A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation The Euro Head Survey
Ron Pisters et al.
CHEST (2010)
Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach The Euro Heart Survey on Atrial Fibrillation
Gregory Y. H. Lip et al.
CHEST (2010)
Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial
Hans Chnstoph Diener et al.
LANCET NEUROLOGY (2010)
Efficacy and safety of anticoagulant treatment in acute cardioembolic stroke - A meta-analysis of randomized controlled trials
Maurizio Paciaroni et al.
STROKE (2007)
Early recurrence of ischemic stroke in Japanese patients: The Japan standard stroke registry study
Kazunori Toyoda et al.
CEREBROVASCULAR DISEASES (2007)
Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation - The AnTicoagulation and risk factors in atrial fibrillation (ATRIA) study
MC Fang et al.
CIRCULATION (2005)
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients
S Schulman et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Validation of clinical classification schemes for predicting stroke - Results from the national registry of Atrial Fibrillation
BF Gage et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Ischemic stroke subtypes - A population-based study of functional outcome, survival, and recurrence
GW Petty et al.
STROKE (2000)
Share Paper
